Method and system for identifying a potential lead failure in an implantable medical device

• US 8,391,980 B2
• Filed: 07/07/2009
• Issued: 03/05/2013
• Est. Priority Date: 07/07/2009
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Bornzin, Gene A., Poore, John W., Williamson, Richard, Mouchawar, Gabriel A., Fain, Eric S.
• Primary Examiner(s): Lavert, Nicole F
• Application Number:
  US12/498,982
• Publication Number:
  US 20110009918A1
• Time in Patent Office: 1,337 Days
• Field of Search: 607/27, 607/48, 607/116
• US Class Current: 607/27
• CPC Class Codes: A61N 1/37 Monitoring; Protecting
• CPC Class Codes: A61N 1/3706 Pacemaker parameters stimulation threshold A61N1/371
• CPC Class Codes: A61N 1/371 Capture, i.e. successful stimulation
• CPC Class Codes: G01R 31/54 Testing for continuity

Abstract

A method for detecting potential failures by a lead of an implantable medical device is provided. The method includes sensing a first signal over a first channel between a first combination of electrodes on the lead and sensing a second signal from a second channel between a second combination of electrodes on the lead. The method determines whether at least one of the first and second signals is representative of a potential failure in the lead and identifies a failure and the electrode associated with the failure based on which of the first and second sensed signals is representative of the potential failure. Optionally, when the first and second sensed signals are both representative of the potential failure, the method further includes determining whether the first and second sensed signals are correlated with one another. When the first and second sensed signals are correlated, the method declares an electrode common to both of the first and second combinations to be associated with the failure.

Claims

1. A method for detecting potential failures by an implantable medical lead, comprising:

sensing a first signal over a first channel between a first combination of electrodes on the lead;

sensing a second signal from a second channel between a second combination of electrodes on the lead;

comparing a first cardiac rate of the first signal to a second cardiac rate of the second signal;

determining if the first and second signals are physiologic if the first cardiac rate is approximately equal to the second cardiac rate;

determining whether at least one of the first and second signals is representative of a potential failure in the lead as a function of the rate comparison and the physiologic determination; and

identifying a failure and the electrode associated with the failure based on which of the first and second sensed signals is representative of the potential failure.

2. The method of claim 1, further comprising:

when the first and second sensed signals are both representative of the potential failure, determining whether the first and second sensed signals are correlated with one another; and

when the first and second sensed signals are correlated, declaring an electrode common to both of the first and second combinations to be associated with the failure.

3. The method of claim 1, further comprising changing at least one of a pacing configuration and a pacer sensing configuration based on the electrode associated with the failure.

4. The method of claim 1, further comprising comparing at least one of amplitude, rate and slew rate of the first and second sensed signals to a predetermined threshold representative of a physiologically acceptable limit for the corresponding one of amplitude, rate and slew rate.

5. The method of claim 1, further comprising disabling sensing over at least one of the first and second channels that is associated with the failure, and enabling a different third channel to sense signals from a third combination of electrodes.

6. The method of claim 1, further comprising notifying a physician of existence of the failure and of the type of failure.

7. The method of claim 1, wherein the first combination of electrodes includes a ring electrode and a tip electrode and the second combination of electrodes includes a coil electrode and the tip electrode.

8. The method of claim 1, further comprising declaring a failure of an electrode of the first combination of electrodes when the first signal is representative of a non-physiologic signal and the second signal is representative of a physiologic signal.

9. The method of claim 1, further comprising declaring a failure of an electrode common to both the first and second combinations of electrodes when the first and second signals are both representative of non-physiologic signals.

10. A method for detecting potential failures by an implantable medical lead, comprising:

sensing a first signal over a first channel between a first combination of electrodes on the lead;

determining whether the first signal is representative of a potential failure in the lead;

obtaining a secondary indicator of heart condition; and

utilizing the secondary indicator to confirm an arrhythmia of the heart when the determining operation identifies the lead to include the potential failure.

11. The method according to claim 10, wherein the secondary indicator represents a hemodynamic indicator from one of an impedance plethysmography measurement indicative of stroke volume in the heart, a pressure sensor located in a heart chamber, a heart sound sensor and a peak endocardial acceleration sensor.

12. The method according to claim 10, wherein the secondary indicator is obtained from a hemodynamic sensor, the secondary indicator being tested after the determining operation identifies the potential failure based on the first signal, the secondary indicator being analyzed before delivery of a therapy.

13. The method according to claim 10, wherein the secondary indicator is obtained from a hemodynamic sensor, the method further comprising performing additional analysis of a heart, when the secondary indicator is representative of normal sinus rhythm, before delivering a therapy.